Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic science and healthcare industry. Straight to your inbox once a week.
Psychedelic-assisted therapy at home, How psychedelic medicines might treat depression, Former Chief of Australian Defence Force advocates for MDMA therapy.
Ceruvia on the mechanism of migraine, Psych Capital to list on Aquis Stock Exchange, US federal agency awards US$2.7m to develop psychedelic medicines.
EXCLUSIVE: Biomind Labs' relocation to the UK, Psychedelic research in the UK and Europe, Brain-scanning technology to test efficacy of psychedelic medicine.
Negev Capital and Investing in Psychedelic Healthcare, Landmark gathering of psychedelic executives and scientists in London, Marketing the future of healthcare
MindMed, MM-120 and Dynamic Drug Development; Making psilocybin available to UK cancer patients; Oregon to only allow cultivation of psilocybe cubensis.
Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic science and healthcare industry. Straight to your inbox once a week.
Subscribe to the Psychedelics Newsletter
Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic science and healthcare industry. Straight to your inbox once a week.